Novocure's device shown to slow cancer progression in the brain in trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. HUBS
3. SPY
4. AUTO
5. AAPL
6. AZN
7. TRMD
8. RARE
9. INTU
10. IQST

Go back to Novocure's device shown to slow cancer progression in the brain in trial
(NASDAQ: NVCR) Delayed: 16.72 --0 (-0%)
Previous Close $16.72    52 Week High $28.95 
Open $16.72    52 Week Low $5.95 
Day High $16.72    P/E N/A 
Day Low $16.72    EPS $0.00 
Volume 2,366